Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Net Asset Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Net Asset Quality Index of 25.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.39 Billion minus total liabilities of CN¥4.79 Billion yields net assets of CN¥1.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Hunan Dajiaweikang Pharmaceutical Indust debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Net Asset Quality Index Over Time (2019–2025)
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 25.1%, representing net assets of CN¥1.60 Billion against total assets of CN¥6.39 Billion CNY. For live market cap and overall valuation, see 301126 market cap.
Annual Net Asset Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See 301126 book value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.1% | CN¥1.59 Billion | CN¥6.34 Billion | CN¥4.74 Billion | ▼ -4.8 pp |
| 2024 | 29.9% | CN¥1.85 Billion | CN¥6.18 Billion | CN¥4.33 Billion | ▼ -3.8 pp |
| 2023 | 33.8% | CN¥1.78 Billion | CN¥5.28 Billion | CN¥3.50 Billion | ▼ -12.5 pp |
| 2022 | 46.2% | CN¥1.82 Billion | CN¥3.93 Billion | CN¥2.11 Billion | ▼ -9.9 pp |
| 2021 | 56.1% | CN¥1.68 Billion | CN¥2.99 Billion | CN¥1.32 Billion | ▲ +8.8 pp |
| 2020 | 47.3% | CN¥1.04 Billion | CN¥2.20 Billion | CN¥1.16 Billion | ▼ -1.2 pp |
| 2019 | 48.5% | CN¥977.24 Million | CN¥2.02 Billion | CN¥1.04 Billion | — |